Reuters Health Report: August 3, 2017

Click to View in Browser Thursday, August 3, 2017 U.S. scientists able to alter genes of human embryos U.S. scientists have succeeded in altering the genes of a human embryo to correct a disease-causing mutation, making it possible to prevent the defect from being passed on to future generations. U.S. governors urge Trump to make insurance payments WASHINGTON (Reuters) - Democratic and Republican U.S. governors on Wednesday urged the Trump administration, as well as Congress, to continue funding payments to health insurance companies that make Obamacare plans affordable, calling it critical to stabilizing the insurance marketplace. FDA panel votes against approval of J&J arthritis drug (Reuters) - The benefits of Johnson & Johnson's experimental rheumatoid arthritis drug sirukumab do not outweigh the risks, an advisory panel to the U.S. Food and Drug Administration concluded on Wednesday. Veiled marketing: Anti-smoking groups slam Indonesia's Big Tobacco JAKARTA (Reuters) - Anti-smoking groups in Indonesia have slammed Big Tobacco for promoting sales by giving retailers cash rewards, shopping vouchers and even money to renovate, urging authorities to enforce advertising curbs to safeguard public health. League considering working with NFLPA on marijuana study (The Sports Xchange) - The NFL has reached out to the NFL Players' Association in hopes of joining its study of using marijuana as a potential pain management tool for the league's ailing players, according to The Washington Post. UK finds Roche bladder cancer drug too costly for routine use LONDON (Reuters) - Britain's healthcare cost-effectiveness agency NICE has decided Roche's new immunotherapy drug Tecentriq is too expensive to justify its routine use to treat bladder cancer, but still hopes it can be used in certain circumstances. Stopping statins after stroke may increase second-stroke risk (Reuters Health) - - Stopping cholesterol-lowering drugs soon after a stroke may increase the risk of a second stroke, according to a new study from Thailand. Hansa Medical shares gain on good kidney transplant drug news LONDON (Reuters) - Shares in Sweden's Hansa Medical jumped 12 percent on Thursday after research showed its experimental drug allowed doctors to perform successful kidney transplants in 24 out of 25 patients with a particularly high risk of organ rejection. Face-to-face therapy best to treat binge eating disorder (Reuters Health) - - People should opt for face-to-face cognitive behavioral therapy if they're looking for the fastest way to address their binge eating disorder, suggests a new study from Germany. Can a drink a day keep diabetes away? (Reuters Health) - - People who enjoy one beer or glass of wine several days a week may be less likely to develop diabetes than drinkers who tend to have all their cocktails on a Saturday night, a Danish study suggests. Related Video New York City turns organic waste into green energy World's biggest heart - from a blue whale - displayed in Toronto A quick-fix on the day's news delivered when you want it. Register Today A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today » » MORE NEWSLETTERS - 3 Times Square New York, NY 10036 USA © Copyright 2017 Thomson Reuters Ensure delivery of Reuters Newsmails, add newsletters@email.reuters.com to your address book. Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook